Trulieve Cannabis Corp.
TCNNF
$3.94
-$0.02-0.51%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.05% | 4.94% | 3.30% | 7.68% | 4.35% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.05% | 4.94% | 3.30% | 7.68% | 4.35% |
| Cost of Revenue | -7.49% | -14.27% | -16.07% | -13.10% | -8.30% |
| Gross Profit | 5.42% | 21.56% | 21.22% | 28.25% | 15.72% |
| SG&A Expenses | 17.24% | 64.02% | 58.36% | 6.89% | 1.26% |
| Depreciation & Amortization | 5.67% | 5.30% | 5.10% | 7.77% | -6.28% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.86% | 17.18% | 13.79% | -3.71% | -4.46% |
| Operating Income | -21.50% | -98.55% | -116.62% | 160.02% | 117.89% |
| Income Before Tax | -36.37% | -246.25% | -193.54% | 111.84% | 2,644.50% |
| Income Tax Expenses | -5.36% | 4.72% | 29.32% | 39.53% | 56.31% |
| Earnings from Continuing Operations | -36.82% | -65.21% | -162.79% | 96.87% | 31.52% |
| Earnings from Discontinued Operations | -19.44% | -160.07% | 44.11% | 97.48% | 95.59% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -49.72% | 30.76% | 264.30% | -87.93% | 79.67% |
| Net Income | -42.42% | -78.83% | -137.13% | 97.02% | 64.01% |
| EBIT | -21.50% | -98.55% | -116.62% | 160.02% | 117.89% |
| EBITDA | -8.92% | -40.91% | -40.31% | 46.07% | 33.38% |
| EPS Basic | -41.22% | -77.90% | -135.57% | 97.04% | 64.12% |
| Normalized Basic EPS | -30.13% | -175.42% | -383.93% | 491.51% | 445.54% |
| EPS Diluted | -41.22% | -77.90% | -135.57% | 97.04% | 64.12% |
| Normalized Diluted EPS | -30.13% | -175.42% | -383.93% | 491.51% | 445.54% |
| Average Basic Shares Outstanding | 0.86% | 0.53% | 0.67% | 0.67% | 0.31% |
| Average Diluted Shares Outstanding | 0.86% | 0.53% | 0.67% | 0.67% | 0.31% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |